General Information of This Drug (ID: DMRGSKK)

Drug Name
Gadoteridol   DMRGSKK
Synonyms ProHance; SQ-32692; GD-HP-DO 3A; Gadolinium-HP-D03A
Indication
Disease Entry ICD 11 Status REF
Brain disease 8C70-8E61 Approved [1]
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Meglumine gadoterate + Gadoteridol DC9J6WW Meglumine gadoterate Motor Function [2]
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 ClinicalTrials.gov (NCT04373564) Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years